Advisory Committee meets
Research portfolio and future expansion of Australian Centre for Neutron Scattering discussed
Showing 2361 - 2380 of 2826 results
Facilities meeting
Australian Centre for Neutorn Scattering - National Deuteration Facility Advisory Committee meets
Excellence in Innovation Award for "Microclimates for high-value crops"
Principal RF Engineer
Role at ANSTO
10MV ANTARES Accelerator
The 10MV tandem accelerator ANTARES is a state-of-the-art facility for ion beam analysis and accelerator mass spectrometry.
BILBY receives its operating licence
Accelerator Scientist, Centre for Accelerator Science
Role at ANSTO
Supercomputing to track the sun's history
Supercomputing power helps unlock secrets in the ice.
Applications Open for the International Synchrotron Access Program (ISAP)
The International Synchrotron Access Program (ISAP) is administered by the Australian Synchrotron and is designed to assist Australian-based synchrotron users to access overseas synchrotron related facilities.
Innovation Precinct featured in Australian Government statement of principles
ANSTO’s Innovation Precinct has been identified as an “emerging precinct” in the Federal Government’s Statement of Principles for Australian Innovation Precincts.
New Magnetometer has arrived
Technical Information - Bilby
Specifications
Applications - Taipan
Applications, Recent results, Publications
Neutron Reflectometry Instrument Scientist
Role at ANSTO
Senior Scientist - Powder Diffraction
Helen's research interests focus on determining the thermoelastic properties and crystal chemistry of a range of minerals which are of interest in a variety of environmental, planetary geology and industrial settings.
Significant milestone achieved in the joint project with Monash University to construct noble-gas polariser for MRI
Celebrating two years of reliable Cold Neutrons at OPAL
Radionuclides in medicine
Radionuclides have been used routinely in medicine for more than 60 years. Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs to diagnose or treat disease. The radionuclides used in medicine have half-lives ranging from a few minutes to several days to minimise the patient's radiation dose.
Students will:
- use MS Excel to construct simple graphs of decay of three unknown medical radionuclides
- use their graph to calculate the half-life of the radionuclides
- determine the identity and use of each radionuclide using the background information provided.
Collaborators - Planetary Materials
We are part of the Planetary Science community in Australia
Sydney